High-Risk Credit Borrowing Patterns: A Comparison of Cancer With Major Chronic Diseases Pancreatic adenocarcinoma (PDAC) unfortunately remains a highly ... novel therapeutic approaches have made ...

A team led by researchers at the Technical University of Munich (TUM) has, for the first time, grown tumor ...

Branched organoids embedded in collagen gels can recapitulate the phenotypic landscape and pronounced molecular and morphological heterogeneity of pancreatic ductal adenocarcinoma. The role of ...

Researchers have successfully developed a deep learning model that classifies pancreatic ductal adenocarcinoma ... applicable tool for triaging patients for molecular testing.

Zenocutuzumab is the first FDA-approved treatment for NRG1-positive NSCLC and pancreatic adenocarcinoma. The eNRGy study demonstrated a 33% overall response rate in NSCLC and 40% in pancreatic ...

The pancreatic cancer diagnostic met its primary endpoint, exceeding the predefined accuracy criteria in a clinical evaluation study.

Immunovia announces positive outcome and strong accuracy in the clinical validation of its next-generation test for pancreatic cancer: Lund, Sweden Tuesday, December 10, 2024, 09: ...